NCT01302951 Penetration of Moxifloxacin Into Liver Tissue of Patients Undergoing Liver Resection. Status COMPLETED Phase PHASE4
NCT01298570 Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT01297530 Clinical Study to Evaluate the Maximum Tolerated Dose of BAY87-2243 in Patients With Advanced Malignancies Status TERMINATED Phase PHASE1
NCT01295294 Management of Initial Bleeding/Spotting Associated With the Levonorgestrel-releasing Intrauterine System (MIRENA) Status COMPLETED Phase PHASE4
NCT01294644 Evaluation of Safety and Efficacy of Deoxycholic Acid Injection (ATX-101) in the Reduction of Submental Fat Status COMPLETED Phase PHASE3
NCT01294215 High Dose BAYA1040_Nifedipine: a Long Term Combination Study Status COMPLETED Phase PHASE3
NCT01289821 First Line Treatment of Metastatic Colorectal Cancer With mFOLFOX6 in Combination With Regorafenib Status COMPLETED Phase PHASE2
NCT01280591 Evaluate Analgesic/Sedative Efficacy of Naproxen Sodium and Diphenhydramine in Patients With Postsurgical Dental Pain Status COMPLETED Phase PHASE3
NCT01271712 Study of Regorafenib as a 3rd-line or Beyond Treatment for Gastrointestinal Stromal Tumors (GIST) Status COMPLETED Phase PHASE3
NCT01270854 Normal Saline Versus Plasmalyte in Initial Resuscitation of Trauma Patients Status COMPLETED Phase NA
NCT01266408 INAS-FOCUS (International Active Surveillance Study - Folate in Oral Contraceptives Utilization Study) Status COMPLETED Phase N/A
NCT01263951 Study of Everolimus and Sorafenib in Patients With Advanced Thyroid Cancer Who Progressed on Sorafenib Alone Status UNKNOWN Phase PHASE2
NCT01260870 European Study of POBA Versus Cotavance(R) Paclitaxel Coated Balloon for the Treatment of Infrapopliteal Lesions in Critical Limb Ischemia (EURO CANAL) Status TERMINATED Phase PHASE2
NCT01258660 Assessment of the Pharmacodynamic Effect on Plasma Folate and Red Blood Cell Folate and Comparison of the Folate Metabolites During the 24 Weeks of Treatment (Yasmin + Metafolin Versus Yasmin + Folic Acid) Followed by a 20 Week Elimination Phase of Folate Status COMPLETED Phase PHASE1
NCT01257984 Study to Investigate Compliance With the Oral Contraceptive SH T00186D in a Flexible Extended Regimen Supported by a Dispenser With a Reminder Function Status COMPLETED Phase PHASE3
NCT01257919 Safety and Pharmacokinetics of Azelaic Acid Foam, 15% in Papulopustular Rosacea Status COMPLETED Phase PHASE1